Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur Urol Focus ; 7(5): 1137-1142, 2021 Sep.
Article in English | MEDLINE | ID: mdl-33121935

ABSTRACT

BACKGROUND: Non-guideline-directed care (NGDC) is seen in ∼30% of testicular cancer patients and has been identified as a significant predictor of relapse. However, the potential impact of mismanagement on patient quality of life (QoL) is yet to be established. OBJECTIVE: To explore the impact of NGDC on long-term QoL in testicular cancer survivors (TCSs). DESIGN, SETTING, AND PARTICIPANTS: A retrospective review of TCSs, who completed the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) in person or via mail ≥6 mo after completion of treatment, was conducted. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The validated questionnaire evaluates global health status (GHS); cognitive, social, physical, emotional, and role functioning; financial burden; and treatment-specific side effects. RESULTS AND LIMITATIONS: A total of 120 men with a median age of 31.5 (interquartile range: 24-42) yr completed the questionnaire. Thirty-four (28%) men received NGDC: overtreatment (44%), improper imaging (32%), and undertreatment (29%). Men with NGDC presented with a more advanced clinical stage (≥IIA: 64% vs 32%, p = 0.007) and were less likely to undergo surveillance (19% vs 37%, p = 0.016). Patients receiving guideline-directed care reported higher GHS (84.1 vs 77.5, p = 0.015), higher physical function scores (98.5 vs 91.2, p = 0.013), and fewer financial difficulties (5.8 vs 18.6, p = 0.006) than those receiving NGDC. Multivariable linear regression showed a significant association between NGDC and poorer GHS (p = 0.002). Limitations of the study include its retrospective nature, modest sample size due to a 21% response rate, and quality-of-life assessment at a single time point rather than serially over time. CONCLUSIONS: In addition to treatment delay, avoidable morbidity, and higher rates of relapse, NGDC leads to inferior global QoL, worse physical functioning, and more financial stress. PATIENT SUMMARY: We have previously shown how mismanagement of testicular cancer results in a higher rate of disease relapse. In this study, we emphasize how the lack of adherence to standard treatment guidelines can lead to worse quality of life outcomes and financial stress in testicular cancer survivors.


Subject(s)
Quality of Life , Testicular Neoplasms , Humans , Male , Neoplasms, Germ Cell and Embryonal , Recurrence , Retrospective Studies , Survivors , Testicular Neoplasms/therapy
2.
Can J Urol ; 21(4): 7393-5, 2014 Aug.
Article in English | MEDLINE | ID: mdl-25171286

ABSTRACT

Osteosarcoma is a highly malignant soft tissue tumor. Bladder extra-skeletal osteosarcomas are very rare, and only few cases are reported in the English medical literature. This case is the third one of its kind to be reported consisting of a bladder diverticulum osteosarcoma. Compared to urothelial bladder carcinoma, urinary bladder osteosarcomas have a poorer prognosis. Biopsy and immunochemical staining are critical for the diagnosis. Treatment regimens vary based on the stage of the disease. However, choosing the best option for treatment is still unclear, due to the scarcity of cases available.


Subject(s)
Osteosarcoma/diagnosis , Sarcoma/diagnosis , Urinary Bladder Neoplasms/diagnosis , Aged , Biopsy , Cystectomy , Fatal Outcome , Humans , Male , Osteosarcoma/pathology , Osteosarcoma/surgery , Prognosis , Sarcoma/pathology , Sarcoma/surgery , Treatment Outcome , Urinary Bladder Neoplasms/pathology , Urinary Bladder Neoplasms/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...